Cresco Labs Inc. (CSE:CL)

Market Cap	428.28M
Revenue (ttm)	921.56M
Net Income (ttm)	-72.70M
Shares Out	356.90M
EPS (ttm)	-0.21
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	249,144
Average Volume	275,137
Open	1.190
Previous Close	1.200
Day's Range	1.090 - 1.230
52-Week Range	0.600 - 2.200
Beta	1.72
RSI	41.03
Earnings Date	Mar 12, 2026

About Cresco Labs

Cresco Labs Inc. cultivates, manufactures, and sells retail and medical cannabis products in the United States and Germany. It provides cannabis in flowers, vape pens, live resins, disposable pens, and extracts under the Cresco brand; vape carts, vape pens, flower, popcorn, shake, pre-rolls, shorties, and concentrates under the High Supply brand; vapes and gummies under the Good News brand; vapes and edibles under the Wonder Wellness Co. brand; and tinctures, capsules, salves, and sublingual oils under the Remedi brand. The company offers canna...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1990
• Employees: 2,900
• Stock Exchange: Canadian Securities Exchange
• Ticker Symbol: CL

Financial Performance

In 2024, Cresco Labs's revenue was $715.76 million, a decrease of -5.33% compared to the previous year's $756.06 million. Losses were -$74.44 million, -57.59% less than in 2023.

Financial numbers in USD